Renin, genes, MicroRNAs, and renal mechanisms involved in hypertension

Hypertension

Volumn 65, Issue 5, 2015, Pages 956-962

  Morris, Brian J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; MICRORNA; MICRORNA 181A; PRORENIN; RENIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; TRANSCRIPTOME;

3' UNTRANSLATED REGION; ADRENERGIC STIMULATION; ARTICLE; DISEASE COURSE; ESSENTIAL HYPERTENSION; GENE CONTROL; GENE EXPRESSION; GENE ISOLATION; GENETIC ASSOCIATION; HUMAN; HYPERTENSION; KIDNEY PROXIMAL TUBULE; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RNA SEQUENCE; ANIMAL; BIOSYNTHESIS; BLOOD PRESSURE; GENE EXPRESSION REGULATION; GENETICS; KIDNEY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; BLOOD PRESSURE; GENE EXPRESSION REGULATION; HUMANS; HYPERTENSION; KIDNEY; MICRORNAS; RENIN; RENIN-ANGIOTENSIN SYSTEM; TRANSCRIPTOME;

EID: 84930985217     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.114.04366     Document Type: Article

References (128)

1. Tigerstedt R, Bergman PG. Niere und Kreislauf. (The kidneys and the circulation.) Skandinav Arch Physiol. 1897; 7: 274-287
2. Blacket RB, Depoorter A, Pickering GW, Sellers AL, Wilson GM. Hypertension produced in the rabbit by long continued infusions of renin. Clin Sci. 1950; 9: 223-245
3. Goldblatt H, Lynch J, Hanzal RF, Summerville WW. Studies on experimental hypertension: I. The production of persistent elevation of systolic blood pressure by means of renal ischemia. J Exp Med. 1934; 59: 347-379
4. Borst JG, Borst-de Geus A. Hypertension explained by Starling's theory of circulatory homoeostasis. Lancet. 1963; 1: 677-682
5. Guyton AC, Coleman TG, Cowley AV Jr, Scheel KW, Manning RD Jr, Norman RA Jr. Arterial pressure regulation. Overriding dominance of the kidneys in long-Term regulation and in hypertension. Am J Med. 1972; 52: 584-594
6. Dahl LK, Heine M. Primary role of renal homografts in setting chronic blood pressure levels in rats. Circ Res. 1975; 36: 692-696
7. Lifton RP. Genetic dissection of human blood pressure variation: common pathways from rare phenotypes. Harvey Lect. 2004; 100: 71-101
8. Laragh JH, Sealey JE. Renin-Angiotensin-Aldosterone system and the renal regulation of sodium, potassium, and blood pressure homeostasis. Handbook of Physiology. Renal Physiology. Bethesda, MD: American Physiological Society; 1992: 1409-1541
9. Laragh JH, Sealey JE. The plasma renin test reveals the contribution of body sodium-volume content (V) and renin-Angiotensin (R) vasoconstriction to long-Term blood pressure. Am J Hypertens. 2011; 24: 1164-1180. doi: 10.1038/ajh.2011.171
10. Johnson RJ, Lanaspa MA, Sanchez-Lozada LG, Rodriguez-Iturbe B. Invited review-The discovery of hypertension, evolving views on the role of the kidneys, and current hot topics. Am J Physiol Renal Physiol. 2014: ajprenal 00503 02014. doi: 10.1152/ajprenal.00503.2014
11. Gonzalez AA, Prieto MC. Renin and the (pro)renin receptor in the renal collecting duct: Role in the pathogenesis of hypertension. Clin Exp Pharmacol Physiol. 2015; 42: 14-21. doi: 10.1111/1440-1681.12319
12. Giani JF, Janjulia T, Taylor B, Bernstein EA, Shah K, Shen XZ, McDonough AA, Bernstein KE, Gonzalez-Villalobos RA. Renal generation of angiotensin II and the pathogenesis of hypertension. Curr Hypertens Rep. 2014; 16: 477. doi: 10.1007/s11906-014-0477-1
13. Coffman TM. The inextricable role of the kidney in hypertension. J Clin Invest. 2014; 124: 2341-2347. doi: 10.1172/JCI72274
14. Navar LG, Kobori H, Prieto MC, Gonzalez-Villalobos RA. Intratubular renin-Angiotensin system in hypertension. Hypertension. 2011; 57: 355-362. doi: 10.1161/HYPERTENSIONAHA.110.163519
15. Prieto-Carrasquero MC, Botros FT, Kobori H, Navar LG. Collecting duct renin: a major player in angiotensin II-dependent hypertension. J Am Soc Hypertens. 2009; 3: 96-104. doi: 10.1016/j.jash.2008.11.003
16. Navar LG, Kobori H, Prieto-Carrasquero M. Intrarenal angiotensin II and hypertension. Curr Hypertens Rep. 2003; 5: 135-143
17. Ramkumar N, Kohan DE. Role of collecting duct renin in blood pressure regulation. Am J Physiol Regul Integr Comp Physiol. 2013; 305: R92-R94. doi: 10.1152/ajpregu.00191.2013
18. Ramkumar N, Ying J, Stuart D, Kohan DE. Overexpression of renin in the collecting duct causes elevated blood pressure. Am J Hypertens. 2013; 26: 965-972. doi: 10.1093/ajh/hpt071
19. Ramkumar N, Stuart D, Rees S, Hoek AV, Sigmund CD, Kohan DE. Collecting duct-specific knockout of renin attenuates angiotensin II-induced hypertension. Am J Physiol Renal Physiol. 2014; 307: F931-F938. doi: 10.1152/ajprenal.00367.2014
20. Morris BJ. Lewis K. Dahl Memorial Lecture - Renin, genes, and beyond: 40 years of molecular discoveries in the hypertension field. Hypertension. 2011; 57: 538-548. doi: 10.1161/HYPERTENSIONAHA.110.166967
21. Finkielman S, Nahmod VE. In vitro production of angiotensin I by renal glomeruli. Nature. 1969; 222: 1186-1188
22. Morris BJ, Johnston CI. Identification of "angiotensin immunoreactive material" in rat kidney. Endocrinology. 1977; 100: 1409-1417. doi: 10.1210/endo-100-5-1409
23. Morris BJ, Johnston CI. Renin substrate in granules from rat kidney cortex. Biochem J. 1976; 154: 625-637
24. Mendelsohn FA. Evidence for the local occurrence of angiotensin II in rat kidney and its modulation by dietary sodium intake and converting enzyme blockade. Clin Sci (Lond). 1979; 57: 173-179
25. Morris BJ, Johnston CI. Isolation of renin granules from rat kidney cortex and evidence for an inactive form of renin (prorenin) in granules and plasma. Endocrinology. 1976; 98: 1466-1474. doi: 10.1210/ endo-98-6-1466
26. Morris BJ. Triton WR-1339 injected into rats enters renal renin granules. Am J Physiol. 1988; 255(3 Pt 1): E353-E356
27. Darby IA, Sernia C. In situ hybridization and immunohistochemistry of renal angiotensinogen in neonatal and adult rat kidneys. Cell Tissue Res. 1995; 281: 197-206
28. Sachetelli S, Liu Q, Zhang SL, Liu F, Hsieh TJ, Brezniceanu ML, Guo DF, Filep JG, Ingelfinger JR, Sigmund CD, Hamet P, Chan JS. RAS blockade decreases blood pressure and proteinuria in transgenic mice overexpressing rat angiotensinogen gene in the kidney. Kidney Int. 2006; 69: 1016-1023. doi: 10.1038/sj.ki.5000210
29. Morris BJ, Lumbers ER. The activation of renin in human amniotic fluid by proteolytic enzymes. Biochim Biophys Acta. 1972; 289: 385-391
30. Morris BJ. Activation of human inactive ("pro-") renin by cathepsin D and pepsin. J Clin Endocrinol Metab. 1978; 46: 153-157. doi: 10.1210/ jcem-46-1-153
31. Morris BJ. Properties of the activation by pepsin of inactive renin in human amniotic fluid. Biochim Biophys Acta. 1978; 527: 86-97
32. Day RP, Morris BJ. Properties of inactive renin in human plasma. Clin Exp Pharmacol Physiol. 1979; 6: 611-624
33. Morris BJ. Renin: from pro to promoter. Bioessays. 2003; 25: 520-527. doi: 10.1002/bies.10269
34. Morris BJ, McGirr JG. Direct evidence, using Pro-Phe-ArgCH2Cl, that plasma kallikrein has a role in acid activation of inactive renin in plasma from normal subjects. Biomed Res. 1981; 2: 552-559
35. Morris BJ. New possibilities for intracellular renin and inactive renin now that the structure of the human renin gene has been elucidated. (Editorial review). Clin Sci. 1986; 71: 345-355
36. Catanzaro DF, Mullins JJ, Morris BJ. The biosynthetic pathway of renin. J Biol Chem. 1983; 258: 7364-7368
37. Morris BJ, Catanzaro DF, Cam GR, Charnock PP, Baker AR, Shine J. Identification of bacterial colonies expressing cloned recombinant DNA coding for renin. Clin Sci. 1982; 63: 147s-148s.
38. Morris BJ, Catanzaro DF, Cam GR. Renin synthesis and gene cloning. Clin Exp Pharmacol Physiol Suppl. 1982; 7: 9-20
39. Catanzaro DF, Morris BJ. Biosynthesis of preprorenin. Studies using whole tissue, a cell-free system, and E. coli containing cDNA inserted at the PstI site of plasmid pBR322. Clin Exp Hypertens A. 1982; 4: 1939-1963
40. Morris BJ, Catanzaro DF, Mullins JJ, Hardman J, Shine J. Synthesis of mouse renin as a 2-5-33-5 kilodalton pre-pro-Two-chain molecule and use of its cDNA to identify the human gene. Clin Exp Pharmacol Physiol. 1983; 10: 293-297
41. Hardman JA, Hort YJ, Catanzaro DF, Tellam JT, Baxter JD, Morris BJ, Shine J. Primary structure of the human renin gene. DNA. 1984; 3: 457-468
42. Smith DL, Jeyapalan S, Lang JA, Guo XH, Sigmund CD, Morris BJ. Human renin 5-flanking DNA to nucleotide-2750. DNA Seq. 1995; 5: 319-321
43. Griffiths LR, Board PG, Zwi MB, Morris BJ, McLeod JG, Nicholson GA. The B subunit of coagulation factor XIII is linked to renin and the Duffy blood group to a-spectrin on human chromosome 1. Hum Hered. 1989; 39: 107-109
44. Qin H, Chen YH, Yip MY, Lam-Po-Tang PR, Morris BJ. Reassignment of human renin gene to chromosome 1q32 in studies of a (1; 4)(q42; p16) translocation. Hum Hered. 1993; 43: 261-264
45. Morris BJ, Guss JM, Hunter WN, Catanzaro DF. A structural analysis of human renin. Clin Exp Pharmacol Physiol. 1985; 12: 299-304
46. Morris BJ. Human renin protein and gene structures: present and future targets for renin blockade in treatment of hypertension. J Hypertens Suppl. 1989; 7: S9-S14
47. Ishigami T, Kino T, Chen L, Minegishi S, Araki N, Umemura M, Abe K, Sasaki R, Yamana H, Umemura S. Identification of bona fide alternative renin transcripts expressed along cortical tubules and potential roles in promoting insulin resistance in vivo without significant plasma renin activity elevation. Hypertension. 2014; 64: 125-133. doi: 10.1161/ HYPERTENSIONAHA.114.03394
48. Mesterovic N, Catanzaro DF, Morris BJ. Detection of renin mRNA in mouse kidney and submandibular gland by hybridization with renin cDNA. Endocrinology. 1983; 113: 1179-1181. doi: 10.1210/endo-113-3-1179
49. Catanzaro DF, Mesterovic N, Morris BJ. Studies of the regulation of mouse renin genes by measurement of renin messenger ribonucleic acid. Endocrinology. 1985; 117: 872-878. doi: 10.1210/endo-117-3-872
50. Karen P, Morris BJ. Stimulation by thyroid hormone of renin mRNA in mouse submandibular gland. Am J Physiol. 1986; 251(3 Pt 1): E290-E293
51. Lou YK, Robinson BG, Morris BJ. Renin messenger RNA, detected by polymerase chain reaction, can be switched on in rat atrium. J Hypertens. 1993; 11: 237-243
52. Lou YK, Liu DT, Whitworth JA, Morris BJ. Renin mRNA, quantified by polymerase chain reaction, in renal hypertensive rat tissues. Hypertension. 1995; 26: 656-664
53. Morris BJ, Everitt SF. Antihypertensive effect of sialoadenectomy in onekidney, one clip hypertension in the rat. J Hypertens. 1985; 3: 601-605
54. Lou YK, Wen C, Li M, Adams DJ, Wang MX, Yang F, Morris BJ, Whitworth JA. Decreased renal expression of nitric oxide synthase isoforms in adrenocorticotropin-induced and corticosterone-induced hypertension. Hypertension. 2001; 37: 1164-1170
55. Lin RC, Schyvens CG, Zhang Y, Whitworth JA, Morris BJ. Tumor necrosis factor receptor 2 mRNA in rat models of hypertension. Am J Hypertens. 2003; 16: 685-688
56. Morris BJ, Roper KJ. Investigation of the presence of "renopressin" in kidney extracts from rabbits and rats. Hypertension. 1982; 4: 198-204
57. Smith DL, Morris BJ. Transient expression analyses of DNA extending 2.4 kb upstream of the human renin gene. Mol Cell Endocrinol. 1991; 80: 139-146
58. Smith DL, Law RE, Shaw KJ, Do YS, Hsueh WA, Morris BJ. Proximal 2.6 kb of 5-flanking DNA is insufficient for human renin promoter activity in renin-synthesizing chorio-decidual cells. Biochim Biophys Acta. 1994; 1219: 465-474
59. Lang JA, Ying LH, Morris BJ, Sigmund CD. Transcriptional and posttranscriptional mechanisms regulate human renin gene expression in Calu-6 cells. Am J Physiol. 1996; 271(1 Pt 2): F94-100
60. Morris BJ, Smith DL, Law RE, Do YS, Shaw KJ, Hsueh WA. Function of human renin proximal promoter DNA. Kidney Int. 1994; 46: 1516-1521
61. Smith DL, Morris BJ, Do YS, Law RE, Shaw KJ, Hseuh WA. Identification of cyclic AMP response element in the human renin gene. Biochem Biophys Res Commun. 1994; 200: 320-329. doi: 10.1006/bbrc.1994.1451
62. Ying L, Morris BJ, Sigmund CD. Transactivation of the human renin promoter by the cyclic AMP/protein kinase A pathway is mediated by both cAMP-responsive element binding protein-1 (CREB)-dependent and CREB-independent mechanisms in Calu-6 cells. J Biol Chem. 1997; 272: 2412-2420
63. Van Der Weyden L, Adams DJ, Morris BJ. Capacity for purinergic control of renin promoter via P2Y(11) receptor and cAMP pathways. Hypertension. 2000; 36: 1093-1098
64. Shi Q, Black TA, Gross KW, Sigmund CD. Species-specific differences in positive and negative regulatory elements in the renin gene enhancer. Circ Res. 1999; 85: 479-488
65. Yan Y, Jones CA, Sigmund CD, Gross KW, Catanzaro DF. Conserved enhancer elements in human and mouse renin genes have different transcriptional effects in As4.1 cells. Circ Res. 1997; 81: 558-566
66. Petrovic N, Black TA, Fabian JR, Kane C, Jones CA, Loudon JA, Abonia JP, Sigmund CD, Gross KW. Role of proximal promoter elements in regulation of renin gene transcription. J Biol Chem. 1996; 271: 22499-22505
67. Morris BJ. Fluorescence activated cell sorting of transiently transfected As4.1 cells shows renin enhancer directs on/off switching of renin promoter in vitro. Clin Exp Pharmacol Physiol. 2008; 35: 367-371. doi: 10.1111/j.1440-1681.2008.04879.x.
68. Adams DJ, Head GA, Markus MA, Lovicu FJ, Van Der Weyden L, Köntgen F, Arends MJ, Thiru S, Mayorov DN, Morris BJ. Renin enhancer is critical for control of renin gene expression and cardiovascular function. J Biol Chem. 2006; 281: 31753-31761. doi: 10.1074/jbc.M605720200
69. Markus MA, Goy C, Adams DJ, Lovicu FJ, Morris BJ. Renin enhancer is crucial for full response in Renin expression to an in vivo stimulus. Hypertension. 2007; 50: 933-938. doi: 10.1161/ HYPERTENSIONAHA.107.096891
70. Jackson K, Head GA, Morris BJ, Chin-Dusting J, Jones E, La Greca L, Mayorov DN. Reduced cardiovascular reactivity to stress but not feeding in renin enhancer knockout mice. Am J Hypertens. 2007; 20: 893-899. doi: 10.1016/j.amjhyper.2007.02.010
71. Martin S, Markus MA, Morris BJ, Davisson RL, Lawrence AJ, Van Den Buuse M. Does angiotensin interact with dopaminergic mechanisms in the brain to modulate prepulse inhibition in mice?. Neuropharmacology. 2008; 54: 399-404. doi: 10.1016/j.neuropharm.2007.10.008
72. Adams DJ, Beveridge DJ, Van Der Weyden L, Mangs H, Leedman PJ, Morris BJ. HADHB, HuR, and CP1 bind to the distal 3-untranslated region of human renin mRNA and differentially modulate rennin expression. J Biol Chem. 2003; 278: 44894-44903. doi: 10.1074/jbc. M307782200
73. Morris BJ, Griffiths LR. Frequency in hypertensives of alleles for a RFLP associated with the renin gene. Biochem Biophys Res Commun. 1988; 150: 219-224
74. Zee RY, Ying LH, Morris BJ, Griffiths LR. Association and linkage analyses of restriction fragment length polymorphisms for the human renin and antithrombin III genes in essential hypertension. J Hypertens. 1991; 9: 825-830
75. Morris BJ. Molecular genetics links renin to hypertension. Mol Cell Endocrinol. 1991; 75: C13-C18
76. Morris BJ, Benjafield AV, Lin RC. Essential hypertension: genes and dreams. Clin Chem Lab Med. 2003; 41: 834-844. doi: 10.1515/ CCLM.2003.127
77. Morris BJ. Identification of essential hypertension genes. (Review). J Hypertens. 1993; 11: 115-120
78. Morris BJ. Discovery of genes for essential hypertension. In: Ganten D, Lindpaintner K, eds. Molecular Reviews in Cardiovascular Medicine. London: Rapid Science Publishers; 1996: 33-48
79. Morris BJ. Genes for essential hypertension: The first decade of research. In: Frossard PM, Parvez SH, Minami M, Parvez S, Saito H, eds. Progress in Hypertension. Zeist, The Netherlands: VSP International Press; 1999: 1-44
80. Benjafield AV, Wang WY, Morris BJ. No association of angiotensinconverting enzyme 2 gene (ACE2) polymorphisms with essential hypertension. Am J Hypertens. 2004; 17: 624-628. doi: 10.1016/j. amjhyper.2004.02.022
81. Benjafield AV, Jeyasingam CL, Nyholt DR, Griffiths LR, Morris BJ. G-protein β3 subunit gene (GNB3) variant in causation of essential hypertension. Hypertension. 1998; 32: 1094-1097
82. Wang WY, Zee RY, Morris BJ. Association of angiotensin II type 1 receptor gene polymorphism with essential hypertension. Clin Genet. 1997; 51: 31-34
83. Kumar NN, Benjafield AV, Lin RC, Wang WY, Stowasser M, Morris BJ. Haplotype analysis of aldosterone synthase gene (CYP11B2) polymorphisms shows association with essential hypertension. J Hypertens. 2003; 21: 1331-1337. doi: 10.1097/01.hjh.0000059078.43904.bf.
84. Benjafield AV, Katyk K, Morris BJ. Association of EDNRA, but not WNK4 or FKBP1B, polymorphisms with essential hypertension. Clin Genet. 2003; 64: 433-438
85. Speirs HJ, Katyk K, Kumar NN, Benjafield AV, Wang WY, Morris BJ. Association of G-protein-coupled receptor kinase 4 haplotypes, but not HSD3B1 or PTP1B polymorphisms, with essential hypertension. J Hypertens. 2004; 22: 931-936
86. Yang Z, Venardos K, Jones E, Morris BJ, Chin-Dusting J, Kaye DM. Identification of a novel polymorphism in the 3UTR of the l-Arginine transporter gene SLC7A1: contribution to hypertension and endothelial dysfunction. Circulation. 2007; 115: 1269-1274. doi: 10.1161/ CIRCULATIONAHA.106.665836
87. Ying LH, Zee RY, Griffiths LR, Morris BJ. Association of a RFLP for the insulin receptor gene, but not insulin, with essential hypertension. Biochem Biophys Res Commun. 1991; 181: 486-492
88. Zee RY, Lou YK, Morris BJ. Short report: insertion variant in intron 9, but not microsatellite in intron 2, of the insulin receptor gene is associated with essential hypertension. J Hypertens. 1993; 11: 1283-1288
89. Lin RC, Wang WY, Morris BJ. Association and linkage analyses of glucocorticoid receptor gene markers in essential hypertension. Hypertension. 1999; 34: 1186-1192
90. Bennett CL, Schrader AP, Morris BJ. Cross-sectional analysis of Met235->Thr variant of angiotensinogen gene in severe, familial hypertension. Biochem Biophys Res Commun. 1993; 197: 833-839. doi: 10.1006/bbrc.1993.2554
91. Zee RY, Stephen AL, Iwai N, Morris BJ. Association analyses of SA gene variant in essential hypertensives. Am J Hypertens. 1997; 10: 235-242
92. Wang WYS, Adams DJ, Glenn CL, Morris BJ. The Gly460Trp variant of a-Adducin is not associated with hypertension in Australian Anglo- Caucasians. Am J Hypertens. 1999; 12: 632-636
93. Wang WYS, Glenn CL, Zhang W, Nyholt DR, Morris BJ. Exclusion of angiotensinogen locus in molecular basis of human hypertension: Sibpair linkage and association analyses in Australian Anglo-Caucasians. Am J Med Genet. 1999; 87: 53-60
94. Benjafield AV, Iwai N, Ishikawa K, Wang WY, Morris BJ. Overweight, but not hypertension, is associated with SAH polymorphisms in Caucasians with essential hypertension. Hypertens Res. 2003; 26: 591-595
95. Speirs HJ, Morris BJ. WNK4 intron 10 polymorphism is not associated with hypertension. Hypertension. 2004; 43: 766-768. doi: 10.1161/01. HYP.0000120121.43524.cd.
96. Benjafield AV, Morris BJ. Association analyses of endothelial nitric oxide synthase gene polymorphisms in essential hypertension. Am J Hypertens. 2000; 13: 994-998
97. Chambers SM, Morris BJ. Glucagon receptor gene mutation in essential hypertension. Nat Genet. 1996; 12: 122. doi: 10.1038/ng0296-122
98. Morris BJ, Jeyasingam CL, Zhang W, Curtain RP, Griffiths LR. Influence of family history on frequency of glucagon receptor Gly40Ser mutation in hypertensive subjects. Hypertension. 1997; 30: 1640-1641
99. Nielsen R. Genomics: In search of rare human variants. Nature. 2010; 467: 1050-1051. doi: 10.1038/4671050a.
100. Bansal V, Libiger O, Torkamani A, Schork NJ. Statistical analysis strategies for association studies involving rare variants. Nat Rev Genet. 2010; 11: 773-785. doi: 10.1038/nrg2867
101. Zee RY, Lou YK, Griffiths LR, Morris BJ. Association of a polymorphism of the angiotensin I-converting enzyme gene with essential hypertension. Biochem Biophys Res Commun. 1992; 184: 9-15
102. Morris BJ, Zee RY, Schrader AP. Different frequencies of angiotensinconverting enzyme genotypes in older hypertensive individuals. J Clin Invest. 1994; 94: 1085-1089. doi: 10.1172/JCI117423
103. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Bard JM, Bara L, Ricard S. Deletion polymorphism in the gene for angiotensin- converting enzyme is a potent risk factor for myocardial infarction. Nature. 1992; 359: 641-644. doi: 10.1038/359641a0
104. Glenn CL, Wang WY, Morris BJ. Different frequencies of inducible nitric oxide synthase genotypes in older hypertensives. Hypertension. 1999; 33: 927-932
105. Glenn CL, Wang WY, Benjafield AV, Morris BJ. Linkage and association of tumor necrosis factor receptor 2 locus with hypertension, hypercholesterolemia and plasma shed receptor. Hum Mol Genet. 2000; 9: 1943-1949
106. Pausova Z, Gaudet D, Gossard F, Bernard M, Kaldunski ML, Jomphe M, Tremblay J, Hudson TJ, Bouchard G, Kotchen TA, Cowley AW, Hamet P. Genome-wide scan for linkage to obesity-Associated hypertension in French Canadians. Hypertension. 2005; 46: 1280-1285. doi: 10.1161/01. HYP.0000188049.23233.fb
107. Morris BJ. Dissecting hypertension by obesity identifies a locus at 1p36. Hypertension. 2005; 46: 1256-1258. doi: 10.1161/01. HYP.0000188055.13764.dc
108. Speirs HJ, Wang WY, Benjafield AV, Morris BJ. No association with hypertension of CLCNKB and TNFRSF1B polymorphisms at a hypertension locus on chromosome 1p36. J Hypertens. 2005; 23: 1491-1496
109. Benjafield AV, Wang WY, Speirs HJ, Morris BJ. Genome-wide scan for hypertension in Sydney Sibships: the GENIHUSS study. Am J Hypertens. 2005; 18: 828-832. doi: 10.1016/j.amjhyper.2004.12.010
110. Marques FZ, Campain AE, Yang YH, Morris BJ. Meta-Analysis of genome-wide gene expression differences in onset and maintenance phases of genetic hypertension. Hypertension. 2010; 56: 319-324. doi: 10.1161/HYPERTENSIONAHA.110.155366
111. Marques FZ, Campain AE, Davern PJ, Yang YH, Head GA, Morris BJ. Global identification of the genes and pathways differentially expressed in hypothalamus in early and established neurogenic hypertension. Physiol Genomics. 2011; 43: 766-771. doi: 10.1152/ physiolgenomics.00009.2011
112. Marques FZ, Campain AE, Davern PJ, Yang YH, Head GA, Morris BJ. Genes influencing circadian differences in blood pressure in hypertensive mice. PLoS One. 2011; 6: e19203. doi: 10.1371/journal.pone.0019203
113. Marques FZ, Campain AE, Tomaszewski M, Zukowska-Szczechowska E, Yang YH, Charchar FJ, Morris BJ. Gene expression profiling reveals renin mRNA overexpression in human hypertensive kidneys and a role for microRNAs. Hypertension. 2011; 58: 1093-1098. doi: 10.1161/ HYPERTENSIONAHA.111.180729
114. Pravenec M, Churchill PC, Churchill MC, et al. Identification of renal Cd36 as a determinant of blood pressure and risk for hypertension. Nat Genet. 2008; 40: 952-954. doi: 10.1038/ng.164
115. Jackson KL, Marques FZ, Watson AM, Palma-Rigo K, Nguyen-Huu TP, Morris BJ, Charchar FJ, Davern PJ, Head GA. A novel interaction between sympathetic overactivity and aberrant regulation of renin by miR-181a in BPH/2J genetically hypertensive mice. Hypertension. 2013; 62: 775-781. doi: 10.1161/HYPERTENSIONAHA.113.01701
116. Jackson KL, Marques FZ, Nguyen-Huu TP, Stevenson ER, Charchar FJ, Davern PJ, Head GA. MicroRNA-181a mimic inhibits the renin-Angiotensin system and attenuates hypertension in a neurogenic model of hypertension. (Abstract.) In: Abstracts from the High Blood Pressure Research Scientific Sessions 2014; September 9-12, 2014; San Francisco, CA. https://my.americanheart.org/idc/groups/ahamah-public/@wcm/@sop/@ scon/documents/downloadable/ucm-467272.pdf. Abstract No. O38, p44
117. Marques FZ, Gueguen C, Jackson KL, Eikelis N, Nguyen-Huu TP, Abegaz B, Moretti JL, Stevenson ER, Lambert GW, Charchar FL, Davern PJ, Head GA. Renal sympathetic innervation regulates blood pressure by actions on miR-181a renin [abstract]. In: Abstracts From the 36th Annual Scientific Meeting of the High Blood Pressure Research Council of Australia. Hypertension. 2015; 65: e29. doi: 10.1161/HYP.0000000000000022
118. Marques FZ, Romaine SPR, Denniff M, Eales J, Dormer J, Garrelds I, Wojnar L, Musialik K, Raszewska BD, Kiszka B, Duda M, Morris BJ, Samani NJ, Danser AHJ, Bogdanki P, Zukowska-Szczechowska E, Tomaszewski M, Charchar FJ. Kidney and circulating microRNA miR-181a is associated with renin and blood pressure in humans [abstract]. In: Abstracts From the 36th Annual Scientific Meeting of the High Blood Pressure Research Council of Australia. Hypertension. 2015; 65: e37. doi: 10.1161/HYP.0000000000000022
119. Ushio-Yamana H, Minegishi S, Ishigami T, Araki N, Umemura M, Tamura K, Maeda E, Kakizoe Y, Kitamura K, Umemura S. Renin angiotensin antagonists normalize aberrant activation of epithelial sodium channels in sodium-sensitive hypertension. Nephron Exp Nephrol. 2012; 122: 95-102. doi: 10.1159/000348660
120. Rippo MR, Olivieri F, Monsurrò V, Prattichizzo F, Albertini MC, Procopio AD. MitomiRs in human inflamm-Aging: a hypothesis involving MIR-181a, MIR-34a and MIR-146a. Exp Gerontol. 2014; 56: 154-163. doi: 10.1016/j.exger.2014.03.002
121. Schiffrin EL. T lymphocytes: a role in hypertension?. Curr Opin Nephrol Hypertens. 2010; 19: 181-186. doi: 10.1097/MNH.0b013e3283360a2e
122. Harrison DG, Vinh A, Lob H, Madhur MS. Role of the adaptive immune system in hypertension. Curr Opin Pharmacol. 2010; 10: 203-207. doi: 10.1016/j.coph.2010.01.006
123. Gooch JL, Sharma AC. Targeting the immune system to treat hypertension: where are we?. Curr Opin Nephrol Hypertens. 2014; 23: 473-479. doi: 10.1097/MNH.0000000000000052
124. Trott DW, Harrison DG. The immune system in hypertension. Adv Physiol Educ. 2014; 38: 20-24. doi: 10.1152/advan.00063.2013
125. Rodríguez-Iturbe B, Pons H, Quiroz Y, Johnson RJ. The immunological basis of hypertension. Am J Hypertens. 2014; 27: 1327-1337. doi: 10.1093/ajh/hpu142
126. Kirabo A, Fontana V, De Faria AP, et al. DC isoketal-modified proteins activate T cells and promote hypertension. J Clin Invest. 2014; 124: 4642-4656. doi: 10.1172/JCI74084
127. Xie W, Li M, Xu N, Lv Q, Huang N, He J, Zhang Y. MiR-181a regulates inflammation responses in monocytes and macrophages. PLoS One. 2013; 8: e58639. doi: 10.1371/journal.pone.0058639
128. Xie W, Li Z, Li M, Xu N, Zhang Y. MIR-181a and inflammation: miRNA homeostasis response to inflammatory stimuli in vivo. Biochem Biophys Res Commun. 2013; 430: 647-652. doi: 10.1016/j.bbrc.2012.11.097